Resnitzky P, Schonfeld S, Dassa H
Arch Intern Med. 1979 Apr;139(4):483-4.
The association between hyperthyroidism and thrombocytopenia is a known although infrequent clinical condition. Distinct mechanisms are probably active in each particular case, but the thyrotoxic state has been implicated as having a key effect on the fall in the number of platelets. We describe a patient with coexisting Graves' disease and idiopathic thrombocytopenic purpura who showed special refractoriness to treatment of the bleeding condition in the thyrotoxic state, but who promptly responded to treatment when the thrombocytopenia relapsed 2 1/2 years later, while he was euthyroid. Thus, in this case, a clear exacerbating effect of the thyrotoxic state on the thrombocytopenia was observed. We suggest evaluation of the thyroid condition in patients suffering from refractory thrombocytopenia.
甲状腺功能亢进与血小板减少之间的关联是一种已知的临床情况,尽管并不常见。在每个具体病例中可能有不同的机制起作用,但甲状腺毒症状态被认为对血小板数量下降起关键作用。我们描述了一位同时患有格雷夫斯病和特发性血小板减少性紫癜的患者,该患者在甲状腺毒症状态下对出血状况的治疗表现出特殊的难治性,但在2年半后血小板减少症复发且处于甲状腺功能正常状态时,对治疗迅速产生反应。因此,在这个病例中,观察到甲状腺毒症状态对血小板减少症有明显的加重作用。我们建议对难治性血小板减少症患者评估甲状腺状况。